BioTheryX

BioTheryX is a clinical-stage biopharmaceutical company dedicated to restoring protein homeostasis through protein modulation, including protein degradation and multi-kinase inhibition, to develop treatments that extend and improve the quality of life for patients with life-threatening diseases.BioTheryX's primary technology platform focuses on PHM® "molecular glues" targeting protein degradation, enabling the design of small molecules to modulate protein balance. Molecular glues can be used to form protein complexes by attaching them together, making them more stable and enhancing their functionality by binding diseased proteins to "modulator" proteins. This technology leverages the body’s own protein processing system to selectively degrade and remove disease-causing proteins.